Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients.
about
The role of epigenetics in the pathology of diabetic complicationsDistinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of the receptor for advanced glycation end productsClinical Implications of Glucose Variability: Chronic Complications of DiabetesGlycemic variability and glycemic control in the acutely ill cardiac patientImpact of postprandial glycaemia on health and prevention of diseaseExtracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?Influenza Virus and Glycemic Variability in Diabetes: A Killer Combination?Diabetic nephropathy and antioxidants.Adiponectin attenuates high glucose-induced apoptosis through the AMPK/p38 MAPK signaling pathway in NRK-52E cells.Combined use of basal insulin analog and acarbose reduces postprandial glucose in patients with uncontrolled type 2 diabetes.Glycemia and its relationship to outcomes in the metformin in gestational diabetes trial.The Effect of Glucose Fluctuation on Apoptosis and Function of INS-1 Pancreatic Beta CellsAssociation of glycated albumin with the presence of carotid plaque in patients with type 2 diabetes.Fluctuations in HbA1c are associated with a higher incidence of cardiovascular disease in Japanese patients with type 2 diabetesEffect of repaglinide versus glimepiride on daily blood glucose variability and changes in blood inflammatory and oxidative stress markers.Features of glycemic variations in drug naïve type 2 diabetic patients with different HbA1c values.Greater HbA1c variability is associated with increased cardiovascular events in type 2 diabetes patients with preserved renal function, but not in moderate to advanced chronic kidney disease.Low levels of 1,5-anhydro-D-glucitol are associated with vascular endothelial dysfunction in type 2 diabetes.Relationship between modified homeostasis model assessment/correlative serum factors and diabetic retinopathy among type 2 diabetics with insulin therapy in Guangzhou, ChinaConcomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetesType 2 diabetes: postprandial hyperglycemia and increased cardiovascular riskNew therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}Effect of glycemic variability on short term prognosis in acute myocardial infarction subjects undergoing primary percutaneous coronary interventions.α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) studyA randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes mellitus on insulin.Glycaemic variability affects ischaemia-induced angiogenesis in diabetic mice.Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgeryMolecular insights and therapeutic targets for diabetic endothelial dysfunction.Breaking up prolonged sitting reduces postprandial glucose and insulin responses.Oxidative stress, nitric oxide, and diabetes.Association between impaired cardiovascular autonomic function and hypoglycemia in patients with type 1 diabetes.Acute hyperglycemia does not impair microvascular reactivity and endothelial function during hyperinsulinemic isoglycemic and hyperglycemic clamp in type 1 diabetic patientsIslet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetesVisit-to-visit variability of fasting plasma glucose as predictor of ischemic stroke: competing risk analysis in a national cohort of Taiwan Diabetes Study.Importance of perioperative glycemic control in general surgery: a report from the Surgical Care and Outcomes Assessment Program.Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease?HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes.Impaired endothelial function in preadolescent children with type 1 diabetes.Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics.Glycaemic variability is associated with coronary artery calcium in men with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes study.
P2860
Q24609124-6B264CEB-E0A4-49C4-88DD-E014BC0A0518Q24643454-A4F44902-BE57-4958-92FE-1CD72D4731CCQ26801671-190768C7-6294-42CD-BE26-16B3C016B88EQ26821994-CA69479B-CFAB-43AE-9471-3C468D67DDFDQ26862823-62C4FD12-2E5F-44A2-8B72-75F56B301FBCQ28079163-A67263A5-7891-4FD7-94C7-648F27E077E8Q30402798-D81DE9CC-F9EC-47C6-BD34-916825790542Q30486658-029678F0-3D71-4CA2-A318-A7256783E29BQ32176326-44EF4792-4C3E-4EF0-B8AC-F94ECEE0B90AQ33464541-3E9E02AD-1335-494C-8C35-67FC7FC7D9A7Q33556924-89B52522-81A2-4F67-8260-C74B801F2096Q33598321-81BE7AD4-9C81-4100-A63C-5DCB8231AD0BQ33607781-097089C6-C985-44C5-84DF-36851C155692Q33609799-4FCD84F2-321F-447C-B114-160D995D94F3Q33631336-17A03C48-EF4D-4F3F-B7FE-B8DBF6C9D2CFQ33685615-131C6AEF-85D2-4E4A-A7D6-FEBC0602C8AEQ33772931-3A16DFDC-F778-495E-A033-5F8A5E0500A7Q33784296-AC66F4DA-B5A9-43F8-8FE6-A3D08DD93810Q33794986-89B0629D-295F-40F9-BEEC-632E432994EAQ33797616-E48963E1-E2DE-4D72-A6C1-221B9030D728Q33813768-8022E811-649B-4D99-BBF3-A505597D33BCQ33874485-E2D3C9C3-796C-476E-9C11-4A5D94E1CAE8Q33880525-660595EF-1A3C-4896-AFCB-F985E6CA3563Q33883808-2AF1AF49-B5C7-4E07-A039-1723870396BBQ33913060-964E2CC9-85E8-49B3-AA67-A617E2F4B90FQ33950813-B32E379B-B84C-48EB-B95E-EAB1F0C69110Q34016041-31AD4FCC-6B97-4089-9AD2-95E2423EED4FQ34022332-A4B32A1C-6DC8-4BE9-8C6A-DF69B9A571C9Q34030881-02512EDE-C5AD-4E52-82BC-78E36C4DE23BQ34072312-5AD3A0B9-D9F4-4C9E-A762-AB254312D70CQ34073479-B68B1745-190D-4659-9866-AD40CF18258EQ34134045-79A2CF6F-128D-4B06-8FB2-96134CCE2527Q34194600-CECECB75-984A-4545-BC0A-6045D3A9A1CFQ34278597-872D6326-1D55-4503-B1AA-26847E12B893Q34399092-F9E5DFC1-9155-4627-B33E-925D3998BE9CQ34486820-4B867FD4-7A44-4C91-B9A4-4EB65DBC4F1AQ34546548-855D3706-9651-46FA-B7D2-15C179B318C2Q34583363-DA1EC80F-0927-4EAD-B25B-B93C6F3676AEQ34620581-CD9AE07A-AA62-45D3-8E81-107AF26DA43AQ34644351-D095105D-F4B1-43F9-A79D-FB24E5D5FA8D
P2860
Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Oscillating glucose is more de ...... and type 2 diabetic patients.
@en
Oscillating glucose is more de ...... and type 2 diabetic patients.
@nl
type
label
Oscillating glucose is more de ...... and type 2 diabetic patients.
@en
Oscillating glucose is more de ...... and type 2 diabetic patients.
@nl
prefLabel
Oscillating glucose is more de ...... and type 2 diabetic patients.
@en
Oscillating glucose is more de ...... and type 2 diabetic patients.
@nl
P2093
P921
P356
P1433
P1476
Oscillating glucose is more de ...... and type 2 diabetic patients.
@en
P2093
Jessica E Thorpe
Katherine Esposito
Ludovica Piconi
Massimo Boemi
Michael A Ihnat
Roberto Testa
P304
P356
10.2337/DB08-0063
P407
P577
2008-02-25T00:00:00Z